Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ia Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of HW241045 Tablets Following a Single Dose in Healthy Subjects: A Single-center, Randomized, Double-blind, Placebo-controlled Study

NCT07448194 is registered in ClinicalTrials.gov with Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. as lead sponsor.

NCT NCT07448194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07448194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ia Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of HW241045 Tablets Following a Single Dose in Healthy Subjects: A Single-center, Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
November 24, 2025
Completion date
June 30, 2026
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, ipf